RIGI and hepatocellular carcinoma: Previous evidence has demonstrated that the consumption of RIG-I inhibited cell viability and promoted apoptosis in colon cancer cells [23]; moreover, the overexpression of RIG-I promoted apoptosis and death in hepatocellular carcinoma [40].